CD8A and neuroblastoma: Raffaghello et al. [26] reported an immune evasion strategy employed by neuroblastoma cells through the production of a soluble form of MICA, which resulted in decreased expression of NKG2D receptors on CD8+ T cells of healthy controls and decreased cytotoxicity of activated NK cells.